Clinical Approach to Developmental Delay

Pediatric Neurology Framework

1
Symptom Overview
Overview
2
Pathophysiology
Mechanism
3
History Taking
History
4
Physical Examination
Examination
5
Differential Diagnosis
Differential
6
Investigations
Workup
7
Clinical Decision-Making
Algorithm
8
Pearls and Pitfalls
Summary

1. Symptom Overview

Understanding the clinical significance and classification of developmental delay

Developmental delay is one of the most common reasons for pediatric neurology referral, affecting approximately 5-10% of children worldwide. It accounts for a significant proportion of early intervention services, with global developmental delay identified in 1-3% of children under 5 years of age. Early identification is critical, as timely intervention during periods of maximal brain plasticity can significantly improve long-term outcomes. Developmental delay represents not a diagnosis itself, but rather a clinical finding that warrants systematic evaluation to identify underlying etiology and guide appropriate intervention.

Definition

Developmental delay refers to a significant lag in achieving age-appropriate milestones in one or more developmental domains: gross motor, fine motor, speech and language, cognitive, and social-emotional/adaptive. It is typically defined as performance more than 2 standard deviations below the mean on standardized testing, or significant functional impairment in achieving milestones for chronological age. Global developmental delay (GDD) specifically refers to delay in two or more developmental domains in children under 5 years of age.

Key Epidemiology

Overall prevalence: 5-10% of children have delay in at least one developmental domain
Global developmental delay: 1-3% of children under 5 years
Intellectual disability: Approximately 1-2% of the population
Identifiable etiology: Found in 50-70% of children with GDD after comprehensive evaluation
Male predominance: Males are affected 1.5-2 times more frequently than females
Genetic causes: Account for 30-50% of identified etiologies

Classification by Developmental Domain

Domain	Description	Key Milestones to Assess	Conditions to Consider
Gross Motor	Large muscle movements, posture, balance, coordination	Head control (3-4 months), sitting (6-8 months), walking (12-15 months)	Cerebral palsy, muscular dystrophy, spinal muscular atrophy
Fine Motor	Small muscle movements, hand-eye coordination, manipulation	Reaching and grasping (4-5 months), pincer grasp (9-10 months), drawing (2-3 years)	Developmental coordination disorder, peripheral neuropathy
Speech and Language	Receptive and expressive language, articulation	Babbling (6-9 months), first words (12 months), 2-word phrases (24 months)	Hearing impairment, autism spectrum disorder, specific language impairment
Cognitive	Problem-solving, reasoning, memory, learning	Object permanence (8-12 months), symbolic play (18-24 months), follows commands	Intellectual disability, genetic syndromes, metabolic disorders
Social-Emotional/Adaptive	Social interaction, emotional regulation, self-care skills	Social smile (2 months), stranger anxiety (8-9 months), parallel play (2 years)	Autism spectrum disorder, attachment disorders, sensory processing disorder

Classification by Number of Domains Affected

Isolated Developmental Delay

Delay in a single developmental domain with other domains within normal limits. Examples include:

Isolated speech delay: Most common isolated delay; often improves with therapy
Isolated motor delay: May indicate cerebral palsy, muscular dystrophy, or benign hypotonia
Isolated social delay: Warrants evaluation for autism spectrum disorder

Prognosis is generally more favorable; many children “catch up” with appropriate intervention.

Global Developmental Delay

Delay in two or more developmental domains in children under 5 years of age. This term is preferred over “intellectual disability” in young children because:

IQ testing is unreliable in children under 5 years
Early developmental trajectory may not predict later cognitive function
Emphasizes the need for comprehensive evaluation

GDD has a higher likelihood of having an identifiable underlying etiology and requires more extensive investigation.

Classification by Severity

Severity	Standardized Score	Functional Description	Approximate IQ Equivalent
Mild	1-2 standard deviations below mean	May have subtle difficulties; often not identified until school age	50-70 (if persistent)
Moderate	2-3 standard deviations below mean	Noticeable delays; requires support but can achieve some independence	35-50 (if persistent)
Severe	3-4 standard deviations below mean	Significant functional impairment; requires substantial support	20-35 (if persistent)
Profound	>4 standard deviations below mean	Very limited communication and self-care abilities; requires extensive support	<20 (if persistent)

Classification by Clinical Course

Pattern	Description	Suggests	Examples
Static Delay	Skills are acquired but at a slower rate; no loss of previously acquired skills	Fixed insult (prenatal, perinatal, or early postnatal)	Cerebral palsy, chromosomal abnormalities, fetal alcohol syndrome
Developmental Regression	Loss of previously acquired developmental milestones	Progressive or neurodegenerative condition; urgent evaluation required	Rett syndrome, neuronal ceroid lipofuscinosis, leukodystrophies
Developmental Plateau	Slowing or cessation of developmental progress without clear loss of skills	May indicate progressive disorder or environmental factors	Some metabolic disorders, severe psychosocial deprivation

Critical Distinction: Delay vs. Regression

Developmental regression — the loss of previously acquired skills — is a red flag that requires urgent evaluation. Unlike static developmental delay, regression suggests an active, potentially progressive, or treatable underlying process such as metabolic disorders, neurodegenerative diseases, or acquired conditions (seizures, brain tumor, hydrocephalus). Always ask parents: “Has your child ever lost any skills they previously had?”

Age-Specific Considerations

Age Group	Primary Domains of Concern	Key Milestones to Monitor	Common Presentations
0-6 months	Motor, visual tracking, social responsiveness	Head control, visual fixation, social smile, responsive to sounds	Hypotonia, feeding difficulties, lack of visual engagement
6-12 months	Motor, early communication, social interaction	Sitting, babbling, stranger anxiety, reaching for objects	Not sitting by 9 months, no babbling by 12 months, lack of social referencing
12-24 months	Motor, language, play skills	Walking, first words, following simple commands, functional play	Not walking by 18 months, no words by 16 months, limited gestures
2-3 years	Language, cognitive, social	2-3 word phrases, symbolic play, parallel play, increasing independence	Limited vocabulary, echolalia, restricted play patterns, poor social reciprocity
3-5 years	Language, pre-academic, adaptive skills	Sentences, follows multi-step commands, preschool readiness skills	Difficulty following directions, behavioral challenges, poor peer interaction

Key Concept: The “Wait and See” Approach is Outdated

Early identification and intervention are critical. Research demonstrates that intervention during the first three years of life — when brain plasticity is greatest — yields the best outcomes. The concept of “developmental surveillance” emphasizes continuous monitoring at every well-child visit, with standardized screening at 9, 18, and 30 months (and autism-specific screening at 18 and 24 months). Parental concern should always be taken seriously, as parents are often the first to notice developmental differences.

Impact on Child and Family

Impact on the Child

Academic difficulties and learning challenges
Social isolation and peer relationship problems
Increased risk of behavioral and emotional disorders
Reduced self-esteem and self-efficacy
Long-term implications for independence and employment

Impact on the Family

Emotional impact: grief, anxiety, guilt
Financial burden of therapies and medical care
Time demands of appointments and interventions
Impact on siblings and marital relationships
Need for long-term care planning

2. Pathophysiology and Mechanisms

Understanding the underlying mechanisms of developmental delay

Developmental delay results from disruption of normal brain development, which can occur at any point from conception through early childhood. Understanding the mechanisms helps guide diagnostic evaluation and identifies potentially treatable conditions. The developing brain is uniquely vulnerable to insults, but also demonstrates remarkable plasticity, which forms the basis for early intervention strategies.

Normal Brain Development: Key Processes

Developmental Process	Timing	Description	Consequences of Disruption
Neural Tube Formation	3-4 weeks gestation	Formation of the basic neural tube structure	Neural tube defects, anencephaly, spina bifida
Neuronal Proliferation	8-16 weeks gestation	Rapid division of neural progenitor cells	Microcephaly, megalencephaly
Neuronal Migration	12-24 weeks gestation	Movement of neurons to appropriate cortical locations	Lissencephaly, heterotopia, polymicrogyria
Organization	24 weeks gestation – postnatal	Layering of cortex, dendritic arborization, synaptogenesis	Intellectual disability, epilepsy
Myelination	Third trimester – early adulthood	Formation of myelin sheaths around axons	Leukodystrophies, periventricular leukomalacia
Synaptic Pruning	Postnatal – adolescence	Elimination of excess synapses; activity-dependent refinement	Abnormal connectivity (implicated in autism spectrum disorder)

Categories of Pathophysiological Mechanisms

Genetic/Chromosomal

Chromosomal abnormalities (Down syndrome, deletions, duplications)

Single gene disorders (Fragile X, Rett syndrome)

Copy number variants

Epigenetic disorders

Metabolic/Biochemical

Amino acid disorders (phenylketonuria)

Organic acidemias

Lysosomal storage disorders

Mitochondrial disorders

Structural/Acquired

Hypoxic-ischemic injury

Congenital infections (TORCH)

Teratogen exposure

Traumatic brain injury

Environmental/Psychosocial

Severe neglect/deprivation

Malnutrition

Lead toxicity

Chronic illness effects

Mechanisms by Etiology Category

Category	Mechanism	Examples	Clinical Implications
Chromosomal Abnormalities	Gene dosage imbalance leading to abnormal protein expression, disrupted neurodevelopmental pathways	Down syndrome (trisomy 21), Turner syndrome, Klinefelter syndrome, microdeletions (22q11.2, 15q11-13)	Often associated with characteristic dysmorphic features; may have multisystem involvement; recurrence risk depends on mechanism
Single Gene Disorders	Loss or gain of function mutations affecting key proteins in neurodevelopment	Fragile X syndrome (FMR1), Rett syndrome (MECP2), tuberous sclerosis (TSC1/TSC2)	Variable penetrance; targeted therapies emerging for some conditions; genetic counseling essential
Inborn Errors of Metabolism	Enzyme deficiency leading to toxic accumulation or energy deficiency in neurons	Phenylketonuria, maple syrup urine disease, mucopolysaccharidoses, mitochondrial disorders	Some are treatable with dietary modification or enzyme replacement; early diagnosis critical
Hypoxic-Ischemic Injury	Neuronal death due to oxygen/glucose deprivation; selective vulnerability of certain brain regions	Perinatal asphyxia, stroke, near-drowning	Timing and duration of insult determine pattern; therapeutic hypothermia for neonatal encephalopathy
Congenital Infections	Direct neuronal invasion, inflammation, vascular disruption during critical periods	Cytomegalovirus, toxoplasmosis, rubella, Zika virus	Timing of infection determines severity; may have progressive component; prevention strategies important
Teratogen Exposure	Disruption of cell signaling, neuronal migration, or synaptogenesis during critical periods	Fetal alcohol spectrum disorders, valproate embryopathy, maternal diabetes effects	Dose and timing dependent; prevention through preconception counseling; may have characteristic phenotypes
Prematurity	Interruption of normal brain development; vulnerability to hemorrhage and white matter injury	Periventricular leukomalacia, intraventricular hemorrhage complications	Risk increases with decreasing gestational age; white matter injury particularly affects motor pathways

Mechanisms Underlying Specific Developmental Domains

Motor Delay Mechanisms

Upper Motor Neuron Pathology

Corticospinal tract damage (periventricular leukomalacia, stroke)
Results in spasticity, increased reflexes, weakness
Example: Cerebral palsy (spastic type)

Lower Motor Neuron/Muscle Pathology

Anterior horn cell disease, peripheral nerve, neuromuscular junction, or muscle
Results in hypotonia, weakness, decreased reflexes
Examples: Spinal muscular atrophy, muscular dystrophies

Language Delay Mechanisms

Mechanism	Description	Associated Conditions
Hearing Impairment	Absent or distorted auditory input during critical period of language acquisition	Congenital hearing loss, recurrent otitis media with effusion
Language Processing Dysfunction	Abnormal development or function of language cortical areas (Broca’s, Wernicke’s)	Specific language impairment, developmental language disorder
Social Communication Impairment	Impaired social motivation and joint attention affecting language learning context	Autism spectrum disorder
Motor Speech Disorders	Impaired motor planning (apraxia) or execution (dysarthria) of speech	Childhood apraxia of speech, cerebral palsy

Cognitive Delay Mechanisms

Level of Disruption	Mechanism	Examples
Synaptic Function	Abnormal synaptic transmission, receptor function, or plasticity	Fragile X syndrome (mGluR5 dysregulation), Angelman syndrome
Neuronal Connectivity	Abnormal axon guidance, dendritic arborization, or pruning	Autism spectrum disorder, some genetic syndromes
Cellular Energy Metabolism	Insufficient ATP production affecting neuronal function	Mitochondrial disorders
Toxic Accumulation	Buildup of metabolites that damage neurons	Phenylketonuria, lysosomal storage disorders

Often Overlooked: The “Two-Hit” Hypothesis

Many cases of developmental delay result from multiple contributing factors rather than a single cause. A child with a genetic predisposition (first hit) may only manifest clinical delay after an environmental insult (second hit), such as perinatal hypoxia or infection. This explains why siblings with the same genetic variant may have different phenotypes, and why a thorough history should explore all potential contributing factors, not stop at the first identified abnormality.

Critical Periods and Brain Plasticity

Why Early Intervention Works:

The developing brain demonstrates remarkable plasticity — the ability to reorganize and form new neural connections. This plasticity is greatest during “critical periods” when specific brain circuits are being refined through experience. Early intervention leverages this plasticity by providing enriched, targeted experiences during these windows of opportunity. Key principles include:

Experience-dependent plasticity: Neural circuits are strengthened by use and weakened by disuse
Critical periods: Specific windows when certain skills are most readily acquired (e.g., language acquisition peaks before age 5)
Cross-modal plasticity: Other brain regions can be recruited to compensate for damaged areas
Dose-response relationship: Greater intensity and duration of intervention generally yields better outcomes

Mechanisms of Developmental Regression

Red Flag: Understanding Regression Mechanisms

Developmental regression suggests an active pathological process and requires urgent investigation. Key mechanisms include:

Neurodegenerative: Progressive neuronal loss (lysosomal storage disorders, leukodystrophies)
Epileptic encephalopathy: Seizures or epileptiform activity disrupting brain function (Landau-Kleffner syndrome, infantile spasms)
Autoimmune/inflammatory: Immune-mediated damage (autoimmune encephalitis, FIRES)

Metabolic decompensation: Episodic or progressive metabolic crisis
Structural lesions: Hydrocephalus, tumor, vascular malformation
Rett syndrome: Characteristic regression in girls (6-18 months), loss of hand skills and language

Pathophysiology Summary: From Mechanism to Clinical Approach

If You Identify This Pattern	Consider These Mechanisms	Priority Investigations
Global delay + dysmorphic features	Chromosomal or genetic syndrome	Chromosomal microarray, targeted genetic testing
Global delay + regression	Metabolic, neurodegenerative, or epileptic	Metabolic workup, EEG, MRI, consider genetic panel
Motor delay + hypotonia + weakness	Neuromuscular disorder	Creatine kinase, genetic testing (SMN1, DMD), EMG/NCS
Motor delay + spasticity	Upper motor neuron pathology	Brain MRI, consider spine imaging
Language delay + social deficits	Autism spectrum disorder pathophysiology	Autism-specific evaluation, hearing test, Fragile X testing
Isolated language delay	Hearing loss, specific language impairment	Audiologic evaluation (first priority)

3. History Taking

A comprehensive approach to eliciting the developmental delay history

Red Flags — Require Urgent Evaluation

Developmental regression — Loss of previously acquired skills suggests neurodegenerative or metabolic disorder
Loss of consciousness or seizures — May indicate epileptic encephalopathy or structural lesion
Progressive neurological signs — Worsening weakness, ataxia, or movement disorder
Acute change in development — Sudden decline warrants urgent neuroimaging
Macrocephaly with signs of increased intracranial pressure — Headache, vomiting, papilledema

Failure to thrive with developmental delay — Consider metabolic disorder, neglect, or chronic illness
Abnormal eye movements — Opsoclonus, nystagmus may indicate neuroblastoma or brainstem pathology
Hepatosplenomegaly with delay — Suggests storage disorder
Unexplained bruising or injuries — Consider non-accidental injury
Severe hypotonia with weakness — Neuromuscular emergency (spinal muscular atrophy)

Systematic History: The “DEVELOP” Approach

Use the mnemonic “DEVELOP” to ensure comprehensive history taking for developmental delay:

D — Developmental Milestones: Systematically review all domains (gross motor, fine motor, language, cognitive, social). When were milestones achieved? Any skills lost?
E — Early Life and Birth History: Pregnancy complications, delivery, gestational age, birth weight, NICU stay, newborn screening results
V — Verify with Regression Questions: “Has your child ever lost any skills they previously had?” — the critical question
E — Environment and Exposures: Toxins (lead), infections, psychosocial environment, access to stimulation, daycare/school performance
L — Lineage (Family History): Consanguinity, developmental delays, intellectual disability, genetic conditions, early deaths, seizures in relatives
O — Other Medical History: Seizures, vision/hearing concerns, feeding difficulties, chronic illness, hospitalizations, surgeries
P — Parental Concerns and Observations: What specifically concerns the parents? Parents are often the first to notice subtle differences

Detailed Developmental Milestone History

Key Principle: Document Specific Ages

Rather than asking “Is your child’s development normal?”, ask specific questions about when milestones were achieved. Compare against expected ages to quantify the degree of delay. Use phrases like: “At what age did your child first…?” and “Can your child currently…?”

Domain	Key Questions to Ask	Expected Age	Red Flag if Absent By
Gross Motor	“When did they hold their head steady? Sit without support? Walk independently?”	Head control: 3-4 mo; Sitting: 6-8 mo; Walking: 12-15 mo	No head control by 4 mo; Not sitting by 9 mo; Not walking by 18 mo
Fine Motor	“When did they start reaching for toys? Using pincer grasp? Scribbling?”	Reaching: 4-5 mo; Pincer: 9-10 mo; Scribbling: 12-15 mo	No reaching by 5 mo; No pincer by 12 mo; Not using hands purposefully
Language (Expressive)	“When did they start babbling? Say first words? Put words together?”	Babbling: 6-9 mo; Words: 12 mo; 2-word phrases: 24 mo	No babbling by 12 mo; No words by 16 mo; No phrases by 24 mo
Language (Receptive)	“Do they respond to their name? Follow simple commands? Understand questions?”	Name response: 9 mo; Simple commands: 12-15 mo	No response to name by 12 mo; Not following commands by 18 mo
Social/Emotional	“When did they first smile at you? Show stranger anxiety? Play with other children?”	Social smile: 2 mo; Stranger anxiety: 8-9 mo; Parallel play: 2 years	No social smile by 3 mo; No social engagement; No interest in peers by 3 years
Cognitive/Adaptive	“Do they look for hidden toys? Use objects appropriately? Help with dressing?”	Object permanence: 8-12 mo; Functional play: 12-18 mo	No functional play by 18 mo; Not imitating by 24 mo

Birth and Perinatal History

Prenatal History

Maternal health: Chronic conditions (diabetes, hypertension, thyroid disease, epilepsy)
Pregnancy complications: Preeclampsia, gestational diabetes, bleeding, infections
Prenatal care: Adequacy, ultrasound findings, screening results
Maternal infections: TORCH infections (toxoplasmosis, rubella, cytomegalovirus, herpes), Zika, syphilis
Teratogen exposure: Alcohol, tobacco, illicit drugs, medications (especially valproate, phenytoin)
Fetal movements: Normal versus reduced movements

Perinatal and Neonatal History

Gestational age: Term versus preterm (if preterm, calculate corrected age)
Delivery: Vaginal versus cesarean, reason for cesarean, complications
Birth weight: Appropriate for gestational age? Small for gestational age?
Apgar scores: At 1 and 5 minutes
Resuscitation: Need for oxygen, ventilation, chest compressions
NICU admission: Duration, reason (respiratory distress, sepsis, hypoglycemia, seizures, jaundice)
Newborn screening: Results of metabolic and hearing screening
Neonatal seizures: Timing, type, treatment
Feeding difficulties: Weak suck, aspiration, failure to thrive

Targeted Questions by Suspected Cause

Suspected Cause	Key Features	Ask This Question
Autism Spectrum Disorder	Social communication deficits, restricted interests, repetitive behaviors	“Does your child make eye contact? Point to show you things? Play pretend games? Have any unusual repetitive movements or intense interests?”
Hearing Impairment	Language delay with normal social development, response to sounds	“Does your child turn to sounds? Startle to loud noises? Did they pass the newborn hearing screen?”
Cerebral Palsy	Motor delay, abnormal tone, asymmetric movements	“Was there any brain injury at birth? Do they have stiffness or floppiness? Is one side weaker than the other?”
Genetic Syndrome	Dysmorphic features, multiple system involvement, family history	“Does anyone in the family have similar features or developmental problems? Are the parents related to each other?”
Metabolic Disorder	Regression, episodic decompensation, organomegaly	“Are symptoms worse during illness? Any unusual body odor? Unexplained vomiting or lethargy?”
Neuromuscular Disorder	Hypotonia, weakness, motor delay more than cognitive delay	“Is your child floppy? Do they struggle to lift their head or sit? Any difficulty swallowing or breathing?”
Seizure Disorder	Epilepsy, infantile spasms, staring episodes	“Have you noticed any staring spells, jerking movements, or episodes where your child seems ‘not there’?”
Fetal Alcohol Spectrum Disorder	Characteristic facial features, growth restriction, behavioral problems	“Did you drink any alcohol during pregnancy? Even in early pregnancy before you knew?”
Psychosocial Deprivation	Global delay, catch-up with intervention, concerning social circumstances	“Who cares for your child during the day? How much time do they spend interacting with adults? Any concerns about the home environment?”
Lead Toxicity	Cognitive and behavioral problems, pica, old housing	“Do you live in a house built before 1978? Has your child been tested for lead? Do they put non-food items in their mouth?”

Family History: Key Questions

Construct a Three-Generation Pedigree — essential for identifying genetic conditions:

Consanguinity: “Are you and your partner related by blood?” — increases risk of autosomal recessive conditions
Developmental delays: “Has anyone in the family had speech delay, learning difficulties, or intellectual disability?”
Neurological conditions: “Any family members with seizures, cerebral palsy, or muscular dystrophy?”
Psychiatric conditions: “Any family history of autism, ADHD, schizophrenia, or bipolar disorder?”
Early deaths: “Have any children in the family died young or unexpectedly?” — may suggest metabolic or genetic disorder
Pregnancy losses: “Any miscarriages or stillbirths?” — may indicate chromosomal abnormalities
Ethnic background: Certain conditions more common in specific populations (e.g., Tay-Sachs in Ashkenazi Jewish)

Current Functional Status and Supports

Educational and Therapy Services

Early intervention services: Currently receiving? Which therapies?
School placement: Mainstream, special education, early childhood program
Therapies: Speech therapy, occupational therapy, physical therapy, ABA therapy
Response to intervention: Improving, stable, or declining?
Individualized Education Program (IEP): Current goals and progress

Daily Living and Behavior

Self-care: Feeding, dressing, toileting abilities
Communication: How does the child communicate needs?
Behavior: Aggression, self-injury, sleep problems, hyperactivity
Play: Type of play, interaction with peers
Sensory sensitivities: Reactions to sounds, textures, lights

Review of Systems: Don’t Miss These

System	Questions	Why It Matters
Growth	Weight gain, linear growth, head circumference trend	Failure to thrive suggests metabolic, genetic, or neglect; microcephaly or macrocephaly have specific differentials
Vision	Eye contact, tracking objects, concerns about sight	Visual impairment can mimic or contribute to developmental delay
Hearing	Response to sounds, newborn hearing screen results, ear infections	Hearing loss is a treatable cause of language delay
Feeding	Swallowing difficulty, choking, food selectivity, reflux	May indicate oromotor dysfunction, neuromuscular disorder, or autism spectrum disorder
Sleep	Sleep patterns, snoring, movements during sleep	Sleep disorders common in developmental conditions; may affect daytime function
Bowel/Bladder	Constipation, incontinence patterns	Constipation common in neurological conditions; incontinence relates to developmental age
Seizures	Staring spells, jerking, behavioral arrest	Epilepsy common comorbidity; some seizures (infantile spasms) cause regression

Clinical Pearl: The Power of Parental Concern

Research consistently shows that parental concern about development is highly predictive of actual developmental problems. When parents express concern, take it seriously — even if your initial impression is reassuring. The sensitivity of parental concern for identifying developmental delay ranges from 70-80%. Ask open-ended questions: “What concerns you most about your child’s development?” and “What made you decide to seek evaluation now?”

4. Physical Examination

A systematic approach to examining the child with developmental delay

Systematic Framework: Use the “Head to Toe Plus Neuro” approach for complete examination of children presenting with developmental delay. The examination should integrate general pediatric assessment, dysmorphology evaluation, and detailed neurological examination. Allow time for observation of spontaneous behavior and play.

Growth Parameters

Critical First Step: Plot Growth on Appropriate Charts

Growth parameters provide crucial diagnostic clues. Plot weight, length/height, and head circumference on age- and sex-appropriate growth charts. For premature infants, use corrected age until 2 years for weight and length, and 18 months for head circumference. Use syndrome-specific growth charts when available (e.g., Down syndrome, Turner syndrome).

Parameter	What to Look For	Clinical Significance
Weight	Percentile, trend over time, weight-for-length	Failure to thrive: metabolic disorder, neglect, feeding difficulties, chronic illness. Obesity: Prader-Willi syndrome, hypothyroidism
Length/Height	Percentile, proportionality, arm span	Short stature: genetic syndromes (Turner, Noonan), skeletal dysplasias, chronic illness. Tall stature: Sotos syndrome, Fragile X
Head Circumference	Percentile, trend, crossing percentiles	Microcephaly (<3rd percentile): congenital infections, genetic, hypoxic injury. Macrocephaly (>97th): hydrocephalus, megalencephaly syndromes, storage disorders, autism spectrum disorder (some)
Body Proportions	Upper-to-lower segment ratio, arm span	Disproportionate short stature suggests skeletal dysplasia or storage disorder

General Inspection

Begin by observing the child before any hands-on examination. Spend several minutes watching the child play, interact with caregivers, and move spontaneously.

Overall Appearance

Level of alertness: Alert, drowsy, irritable
Interaction: Eye contact, social engagement, response to examiner
Behavior: Appropriate for age? Stereotypies? Self-stimulation?
Play: Purposeful? Symbolic? Repetitive?
Communication: Verbal? Gestures? Points?
Nutritional status: Well-nourished, wasted, obese

Dysmorphic Features

Gestalt: Does the child “look syndromic”?
Face: Distinctive facial features, asymmetry
Hands and feet: Unusual shape, proportions, creases
Skin: Pigmentary abnormalities, birthmarks
Body habitus: Proportions, posture
Resemblance to parents: Features that differ from family

Dysmorphology Examination

Region	Features to Assess	Associated Conditions
Head Shape	Brachycephaly, dolichocephaly, plagiocephaly, prominent forehead, flat occiput	Down syndrome (brachycephaly, flat occiput), craniosynostosis syndromes, Sotos (prominent forehead)
Hair	Texture, color, hairline position, whorls	Abnormal whorls suggest early brain maldevelopment; low hairline in Noonan syndrome
Eyes	Palpebral fissure length and slant, epicanthal folds, hypertelorism, iris abnormalities	Upslanting (Down syndrome), downslanting (Noonan), short fissures (fetal alcohol spectrum disorder), Brushfield spots (Down syndrome)
Ears	Position, rotation, size, shape, pits, tags	Low-set ears (many syndromes), posteriorly rotated (22q11.2 deletion), preauricular pits (branchio-oto-renal syndrome)
Nose	Bridge, tip, philtrum length and shape	Smooth philtrum and thin upper lip (fetal alcohol spectrum disorder), bulbous nose (Smith-Lemli-Opitz)
Mouth	Lip shape, palate, tongue, teeth	Macroglossia (Down syndrome, Beckwith-Wiedemann), high arched palate (many syndromes), cleft palate
Hands	Length, shape, finger proportions, nails, palmar creases	Single palmar crease (Down syndrome), clinodactyly, brachydactyly, arachnodactyly (Marfan), polydactyly
Feet	Shape, toe proportions, sandal gap, creases	Sandal gap (Down syndrome), overlapping toes, rocker-bottom feet (trisomy 18)
Genitalia	Development, anomalies	Hypospadias, cryptorchidism may be part of syndromic presentation

Skin Examination

Neurocutaneous Markers: Don’t Miss These

Skin findings can provide critical diagnostic clues. Examine the entire skin surface in good lighting. Use a Wood’s lamp (ultraviolet light) to enhance detection of hypopigmented lesions.

Finding	Description	Associated Condition
Café-au-lait spots	Flat, light brown macules; ≥6 spots >5mm (prepubertal) or >15mm (postpubertal)	Neurofibromatosis type 1 (with other criteria)
Hypopigmented macules (ash-leaf spots)	White, oval or leaf-shaped patches; best seen with Wood’s lamp	Tuberous sclerosis complex
Shagreen patch	Raised, flesh-colored, orange-peel texture patch (usually lower back)	Tuberous sclerosis complex
Facial angiofibromas	Red papules on nose and cheeks (adenoma sebaceum)	Tuberous sclerosis complex
Port-wine stain	Flat, red-purple vascular malformation; check trigeminal distribution	Sturge-Weber syndrome (if V1 distribution)
Axillary/inguinal freckling	Freckling in skin folds (Crowe sign)	Neurofibromatosis type 1
Hypopigmented hair tuft	White forelock (poliosis)	Waardenburg syndrome (with hearing loss)
Ichthyosis	Dry, scaly skin	Sjögren-Larsson syndrome (with spasticity)

Neurological Examination

The neurological examination is central to evaluating developmental delay. Adapt techniques to the child’s age and developmental level.

Cranial Nerves

Cranial Nerve	How to Assess	Abnormal Findings
I (Olfactory)	Reaction to pleasant/unpleasant smells (older children)	Anosmia: Kallmann syndrome, frontal lobe lesion
II (Optic)	Visual fixation, tracking, blink to threat, fundoscopy	Optic atrophy (metabolic, compressive), papilledema (raised intracranial pressure), cherry-red spot (storage disorders)
III, IV, VI (Oculomotor)	Eye movements, pupil responses, ptosis	Strabismus (common in cerebral palsy, syndromes), nystagmus, limited gaze
V (Trigeminal)	Facial sensation, jaw strength, corneal reflex	Weakness: brainstem lesion
VII (Facial)	Facial symmetry at rest and with movement, taste (older children)	Facial weakness: Möbius syndrome, cerebral palsy
VIII (Vestibulocochlear)	Response to sounds, startle, formal audiometry	Hearing impairment: major cause of language delay
IX, X (Glossopharyngeal, Vagus)	Swallowing, gag reflex, voice quality	Dysphagia, dysarthria: bulbar dysfunction
XI (Accessory)	Shoulder shrug, head turn against resistance	Weakness: rare, usually with other cranial nerve findings
XII (Hypoglossal)	Tongue movement, fasciculations, atrophy	Fasciculations: spinal muscular atrophy; weakness: bulbar palsy

Motor Examination

Component	Assessment Method	Abnormal Findings and Significance
Tone	Passive movement of limbs, pull-to-sit, ventral suspension, observe posture	Hypotonia: central (preserved strength) versus peripheral (weakness). Hypertonia: spasticity (velocity-dependent), rigidity, dystonia
Strength	Observe antigravity movements, resistance to movement, functional tasks	Weakness: proximal (myopathy, SMA) versus distal (neuropathy); focal versus generalized
Bulk	Visual inspection, palpation of muscles	Atrophy: denervation, disuse. Pseudohypertrophy (calves): Duchenne muscular dystrophy
Reflexes	Deep tendon reflexes (biceps, triceps, knee, ankle), plantar response	Hyperreflexia with upgoing toes: upper motor neuron. Hyporeflexia/areflexia: lower motor neuron or muscle
Coordination	Reaching for objects, finger-to-nose (older children), gait observation	Ataxia: cerebellar pathology, posterior fossa tumor

Primitive Reflexes

Primitive Reflexes: Presence and Persistence

Primitive reflexes emerge in infancy and should disappear by specific ages as cortical inhibition develops. Persistence beyond expected age suggests upper motor neuron dysfunction (such as cerebral palsy). Asymmetry suggests focal pathology.

Reflex	How to Elicit	Appears	Should Disappear By
Moro	Sudden head drop or loud noise	Birth	4-6 months
Asymmetric tonic neck reflex (ATNR)	Turn head to side while supine	Birth	6 months
Palmar grasp	Place finger in palm	Birth	4-6 months
Plantar grasp	Press base of toes	Birth	9-12 months
Rooting	Stroke cheek	Birth	4 months
Stepping	Hold upright with feet on surface	Birth	2 months
Parachute	Hold prone and suddenly lower toward surface	8-9 months	Persists

Gait and Posture

Observe Gait (if ambulatory)

Base: Narrow versus wide-based
Symmetry: Equal arm swing, step length
Heel-toe pattern: Toe-walking? Foot drop?
Running: May unmask subtle asymmetry
Tandem walking: Heel-to-toe (cerebellar function)
Gowers’ sign: Rising from floor using hands to “climb up” legs (proximal weakness)

Abnormal Gait Patterns

Spastic diplegic: Scissoring, toe-walking, crouched
Hemiplegic: Circumduction, arm posturing
Ataxic: Wide-based, irregular, lurching
Waddling: Proximal weakness (myopathy)
Toe-walking: Spasticity, autism spectrum disorder, habitual, tight Achilles
Dystonic: Abnormal posturing with movement

Cardiovascular and Abdominal Examination

Cardiovascular

Murmurs: Congenital heart disease associated with many genetic syndromes (Down syndrome: AVSD; Williams syndrome: supravalvular aortic stenosis; 22q11.2 deletion: conotruncal defects)
Pulses: Radiofemoral delay (coarctation)
Blood pressure: All four limbs if indicated

Abdominal

Hepatomegaly: Storage disorders, mitochondrial disease
Splenomegaly: Storage disorders
Hernias: Associated with some syndromes and connective tissue disorders
Diastasis recti: Connective tissue disorders

Developmental Assessment During Examination

Observe and Test Developmental Skills: The examination provides an opportunity to directly assess developmental milestones. Use age-appropriate toys and tasks:

Gross motor: Head control, sitting, standing, walking, running, jumping
Fine motor: Reaching, grasping, transferring, pincer grasp, stacking blocks, drawing
Language: Babbling, words, phrases, following commands, naming objects
Social: Eye contact, social smile, stranger anxiety, joint attention, pretend play
Cognitive: Problem-solving with toys, understanding cause-effect, symbolic play

Expected Findings by Etiology

Condition	Growth	Dysmorphic Features	Neurological Findings	Other
Down Syndrome	Short stature	Upslanting eyes, flat nasal bridge, single palmar crease, sandal gap	Hypotonia, hyperflexibility	Cardiac murmur (40-50%)
Fragile X Syndrome	Often tall, large head	Long face, prominent ears, prominent jaw (postpubertal)	May have hypotonia, hand flapping	Macroorchidism (postpubertal)
Fetal Alcohol Spectrum Disorder	Growth restriction	Short palpebral fissures, smooth philtrum, thin upper lip	Variable, may have hypotonia or coordination problems	Cardiac defects possible
Cerebral Palsy	May be small for age	None specific	Abnormal tone (spasticity, dystonia, or hypotonia), motor impairment, persistent primitive reflexes	May have strabismus
Autism Spectrum Disorder	Usually normal (some have macrocephaly)	Usually none	Usually normal; may have motor stereotypies, toe-walking	Reduced eye contact, repetitive behaviors
Spinal Muscular Atrophy	May have poor weight gain	None	Hypotonia, weakness (proximal > distal), areflexia, tongue fasciculations, alert face	Bell-shaped chest
Duchenne Muscular Dystrophy	Usually normal initially	None	Proximal weakness, Gowers’ sign, calf pseudohypertrophy, toe-walking	May have cardiomyopathy

Important Teaching Point: Normal Examination is Common

Many children with developmental delay — including those with intellectual disability, autism spectrum disorder, and specific learning disorders — have entirely normal physical and neurological examinations. A normal examination does not exclude significant underlying pathology or genetic conditions. Conversely, subtle findings can provide crucial diagnostic clues. The examination should be thorough but should not delay referral for developmental assessment and early intervention when delay is suspected.

5. Differential Diagnosis

Systematic approach organized by probability, pattern, and clinical features

Diagnostic Yield

Comprehensive evaluation identifies an underlying etiology in 50-70% of children with global developmental delay. The yield is highest when there are associated features such as dysmorphism, abnormal neurological examination, or regression. Even when no specific diagnosis is found, systematic evaluation helps guide prognosis, recurrence risk counseling, and intervention planning.

Step-by-Step Approach to Differential Diagnosis

Systematic Approach to Developmental Delay:

Step 1: Characterize the delay — Which domains are affected? Is it isolated or global? What is the severity?
Step 2: Determine the pattern — Is it static, progressive, or regressive? This fundamentally changes the differential.
Step 3: Look for associated features — Dysmorphism, neurological signs, growth abnormalities, multisystem involvement
Step 4: Consider timing of insult — Prenatal, perinatal, or postnatal onset
Step 5: Generate probability-based differential — Start with common causes, then consider less common conditions based on clinical clues

Global Developmental Delay: Causes by Probability

Probability	Category	Examples	Approximate Frequency
COMMON (60-70%)	Genetic/Chromosomal	Down syndrome, Fragile X syndrome, chromosomal microdeletions/microduplications, single gene disorders	30-40%
	Perinatal Insults	Hypoxic-ischemic encephalopathy, periventricular leukomalacia, intraventricular hemorrhage complications	10-15%
	Central Nervous System Malformations	Cortical malformations, agenesis of corpus callosum, holoprosencephaly, neuronal migration disorders	5-10%
	Prenatal Exposures	Fetal alcohol spectrum disorders, congenital infections (cytomegalovirus, toxoplasmosis), teratogenic medications	5-10%
LESS COMMON (15-25%)	Inborn Errors of Metabolism	Phenylketonuria, amino acid disorders, organic acidemias, lysosomal storage disorders, mitochondrial disorders	5-10%
	Neuromuscular Disorders	Spinal muscular atrophy, muscular dystrophies, congenital myopathies, congenital myasthenia	3-5%
	Endocrine Disorders	Congenital hypothyroidism (if missed on newborn screening), growth hormone deficiency	1-2%
UNCOMMON BUT IMPORTANT (5-15%)	Neurodegenerative Disorders	Leukodystrophies, neuronal ceroid lipofuscinoses, Rett syndrome	2-5%
	Epileptic Encephalopathies	Infantile spasms (West syndrome), Lennox-Gastaut syndrome, Landau-Kleffner syndrome	2-3%
	Environmental	Severe psychosocial deprivation, lead toxicity, traumatic brain injury, non-accidental injury	2-5%

Unknown Etiology: 30-50% of Cases

Despite comprehensive evaluation, 30-50% of children with global developmental delay will not have an identifiable cause. This percentage is decreasing as genetic testing advances. Important points for families:

Absence of diagnosis does not mean absence of a real condition
Intervention should not be delayed while pursuing diagnosis
Periodic re-evaluation may yield diagnosis as testing improves or phenotype evolves
Empiric recurrence risk counseling can be provided

Differential by Pattern of Delay

Static Developmental Delay (Most Common)

Skills are acquired but at a slower rate than expected. No loss of previously acquired abilities.

Timing of Insult	Causes	Key Features
Prenatal (First Trimester)	Chromosomal abnormalities, major brain malformations, early congenital infections, teratogen exposure	Often associated with dysmorphic features, may have multisystem involvement
Prenatal (Second/Third Trimester)	Later congenital infections (especially cytomegalovirus), vascular events, migration disorders	May have microcephaly, intracranial calcifications, hearing loss
Perinatal	Hypoxic-ischemic encephalopathy, stroke, hemorrhage, extreme prematurity complications	History of birth complications, NICU stay, neonatal seizures
Postnatal	Meningitis/encephalitis, traumatic brain injury, near-drowning, non-accidental injury	Clear history of event, imaging changes consistent with timing

Developmental Regression (Red Flag)

Regression Requires Urgent Evaluation

Loss of previously acquired skills suggests an active pathological process. Differential includes treatable conditions that require prompt diagnosis.

Category	Conditions	Key Features	Urgency
Epileptic Encephalopathy	Infantile spasms, Lennox-Gastaut syndrome, Landau-Kleffner syndrome (acquired epileptic aphasia), electrical status epilepticus in sleep	Seizures (may be subtle), EEG abnormalities, may respond to treatment	HIGH — Treatable
Metabolic Disorders	Lysosomal storage disorders (mucopolysaccharidoses, Tay-Sachs, Niemann-Pick), mitochondrial disorders, amino acid disorders	Hepatosplenomegaly, coarse features, episodic decompensation, multisystem involvement	HIGH — Some treatable
Leukodystrophies	Metachromatic leukodystrophy, Krabbe disease, adrenoleukodystrophy, Alexander disease	White matter changes on MRI, progressive motor and cognitive decline	MODERATE — Some have treatment
Neuronal Ceroid Lipofuscinoses	Infantile, late infantile, juvenile forms	Seizures, visual loss, motor decline, characteristic EEG and imaging	MODERATE — Emerging therapies
Rett Syndrome	Classic Rett syndrome (MECP2 mutation)	Girls 6-18 months, loss of hand skills and language, hand stereotypies, deceleration of head growth	Genetic diagnosis important
Acquired/Structural	Hydrocephalus, brain tumor, HIV encephalopathy, subacute sclerosing panencephalitis	Focal signs, increased intracranial pressure, infectious exposure history	HIGH — Treatable
Autoimmune	Autoimmune encephalitis (anti-NMDA receptor, others), Rasmussen encephalitis	Acute/subacute onset, psychiatric symptoms, movement disorders, seizures	HIGH — Treatable

Differential by Domain Affected

Isolated Motor Delay

Probability	Condition	Key Distinguishing Features
COMMON	Cerebral palsy	Abnormal tone (spasticity or dyskinesia), persistent primitive reflexes, risk factors (prematurity, perinatal asphyxia)
COMMON	Benign hypotonia / constitutional motor delay	Hypotonia without weakness, normal cognitive development, family history of late walkers, gradual improvement
LESS COMMON	Spinal muscular atrophy	Hypotonia with weakness, areflexia, tongue fasciculations, alert appearance, normal cognition
LESS COMMON	Muscular dystrophies (Duchenne, congenital)	Progressive weakness, elevated creatine kinase, calf pseudohypertrophy (Duchenne), Gowers’ sign
LESS COMMON	Congenital myopathies	Hypotonia, weakness, facial weakness, feeding difficulties, respiratory involvement
UNCOMMON	Spinal cord pathology	Sensory level, bowel/bladder dysfunction, back pain or deformity

Isolated Language Delay

Probability	Condition	Key Distinguishing Features
COMMON	Developmental language disorder (specific language impairment)	Isolated language delay, normal nonverbal cognition, normal hearing, family history of late talkers
COMMON	Hearing impairment	Failed hearing screen, recurrent otitis media, no response to sounds, normal social engagement
COMMON	Autism spectrum disorder	Social communication deficits, restricted interests, repetitive behaviors, language delay often first concern
LESS COMMON	Childhood apraxia of speech	Inconsistent speech errors, difficulty with volitional speech, groping movements, better receptive than expressive
LESS COMMON	Selective mutism	Speaks in some settings but not others (typically speaks at home, not at school), associated anxiety
UNCOMMON	Landau-Kleffner syndrome	Acquired aphasia (loss of language), epileptiform EEG, onset 3-7 years

Isolated Social/Communication Delay

Probability	Condition	Key Distinguishing Features
COMMON	Autism spectrum disorder	Deficits in social-emotional reciprocity, nonverbal communication, relationships; restricted, repetitive behaviors
LESS COMMON	Social (pragmatic) communication disorder	Difficulty with social use of language, no restricted/repetitive behaviors
LESS COMMON	Reactive attachment disorder	History of severe neglect/deprivation, inhibited social behavior, does not seek comfort
UNCOMMON	Intellectual disability with prominent social features	Global delays but social deficits most prominent; some genetic syndromes have characteristic social phenotypes

Anatomical/Etiological Approach

Genetic/Chromosomal

Chromosomal: Down syndrome, deletions/duplications, sex chromosome abnormalities

Single gene: Fragile X, Rett, tuberous sclerosis, neurofibromatosis

Copy number variants: 22q11.2 deletion, 15q11-13 (Angelman/Prader-Willi), 16p11.2

Metabolic/Biochemical

Amino acid: Phenylketonuria, homocystinuria, maple syrup urine disease

Organic acid: Methylmalonic acidemia, propionic acidemia

Lysosomal: Mucopolysaccharidoses, sphingolipidoses

Mitochondrial: Leigh syndrome, MELAS

Structural/Acquired

Malformations: Lissencephaly, polymicrogyria, agenesis of corpus callosum

Vascular: Perinatal stroke, porencephaly

Hypoxic: Hypoxic-ischemic encephalopathy

Infectious: Congenital CMV, meningitis sequelae

Neuromuscular/Other

Motor neuron: Spinal muscular atrophy

Muscle: Muscular dystrophies, congenital myopathies

Endocrine: Hypothyroidism

Environmental: Fetal alcohol, lead, deprivation

Common Genetic Syndromes Associated with Developmental Delay

Syndrome	Genetic Basis	Key Features	Developmental Profile
Down Syndrome	Trisomy 21	Characteristic facies, hypotonia, congenital heart disease, single palmar crease	Mild-moderate intellectual disability; relative strength in social skills
Fragile X Syndrome	FMR1 trinucleotide expansion	Long face, large ears, macroorchidism (postpubertal); often macrocephalic	Mild-severe intellectual disability; hyperactivity, anxiety, autism features common
22q11.2 Deletion (DiGeorge/Velocardiofacial)	22q11.2 microdeletion	Conotruncal heart defects, palatal abnormalities, hypocalcemia, immune deficiency	Learning disabilities to mild intellectual disability; psychiatric risk in adolescence
Williams Syndrome	7q11.23 microdeletion	Elfin facies, supravalvular aortic stenosis, hypercalcemia, friendly personality	Mild-moderate intellectual disability; verbal > visuospatial skills
Angelman Syndrome	15q11-13 (maternal deletion or UPD)	Severe speech impairment, ataxic gait, happy demeanor, seizures, microcephaly	Severe intellectual disability; very limited speech
Prader-Willi Syndrome	15q11-13 (paternal deletion or UPD)	Neonatal hypotonia, feeding difficulties then hyperphagia, obesity, hypogonadism	Mild-moderate intellectual disability; behavioral challenges
Rett Syndrome	MECP2 mutation (usually de novo)	Girls; regression 6-18 months, hand stereotypies, microcephaly, seizures, autonomic dysfunction	Severe intellectual disability after regression
Tuberous Sclerosis Complex	TSC1 or TSC2 mutation	Skin lesions (ash-leaf spots, facial angiofibromas), seizures, cardiac rhabdomyomas, renal angiomyolipomas	Variable; ~50% have intellectual disability; autism common

Prenatal and Perinatal Causes

Category	Specific Causes	Key Historical/Clinical Features
Congenital Infections (TORCH)	Cytomegalovirus (most common), toxoplasmosis, rubella, herpes simplex, syphilis, Zika virus	Microcephaly, intracranial calcifications, hearing loss, chorioretinitis, hepatosplenomegaly
Teratogen Exposure	Fetal alcohol spectrum disorders, valproate, phenytoin, isotretinoin, maternal diabetes	Characteristic facial features (fetal alcohol), neural tube defects, history of exposure
Hypoxic-Ischemic Encephalopathy	Perinatal asphyxia from various causes	Low Apgar scores, neonatal encephalopathy, seizures, need for resuscitation
Prematurity Complications	Periventricular leukomalacia, intraventricular hemorrhage, bronchopulmonary dysplasia effects	Very preterm birth (<32 weeks), NICU course, cranial ultrasound abnormalities
Neonatal Stroke	Arterial ischemic stroke, venous thrombosis	May present with seizures, later hemiparesis, may be asymptomatic initially

Quick Reference: “If You See This, Think This”

Clinical Clue	Think This First	Key Investigation
Regression + seizures	Epileptic encephalopathy, neurometabolic disorder	EEG, metabolic workup, MRI
Hypotonia + weakness + areflexia	Spinal muscular atrophy	SMN1 gene testing
Proximal weakness + calf hypertrophy	Duchenne muscular dystrophy	Creatine kinase, dystrophin gene testing
Hypotonia + characteristic facies + heart defect	Down syndrome	Karyotype or chromosomal microarray
Boy + intellectual disability + large ears + macroorchidism	Fragile X syndrome	FMR1 DNA testing
Girl + regression + hand stereotypies + acquired microcephaly	Rett syndrome	MECP2 gene testing
Hepatosplenomegaly + coarse features + regression	Lysosomal storage disorder	Enzyme assays, urine glycosaminoglycans
Skin lesions (ash-leaf spots) + seizures	Tuberous sclerosis complex	MRI brain, echocardiogram, renal ultrasound, genetic testing
Language delay + normal social skills	Hearing impairment or developmental language disorder	Audiologic evaluation (first)
Social deficits + restricted interests + repetitive behaviors	Autism spectrum disorder	Autism-specific diagnostic evaluation
Smooth philtrum + thin upper lip + short palpebral fissures	Fetal alcohol spectrum disorder	Clinical diagnosis (no definitive test)
Microcephaly + intracranial calcifications	Congenital infection (especially CMV)	CMV PCR (urine, saliva), TORCH serology

6. Diagnostic Investigations

A stepwise, evidence-based approach guided by clinical features

Guiding Principle: Investigation of developmental delay should be individualized based on clinical findings. A tiered approach is recommended, starting with high-yield tests for all children with global developmental delay, followed by targeted investigations based on specific clinical features. The goal is to identify treatable conditions, provide prognostic information, and enable genetic counseling.

First-Tier Investigations: Recommended for All Children with Global Developmental Delay

Investigation	Purpose	What to Look For	Yield/Notes
Chromosomal Microarray (CMA)	Detect copy number variants (deletions, duplications) throughout genome	Pathogenic or likely pathogenic variants; variants of uncertain significance	15-20% diagnostic yield; first-line genetic test; replaces karyotype as initial test
Fragile X DNA Testing	Detect FMR1 trinucleotide repeat expansion	Full mutation (>200 repeats), premutation (55-200 repeats)	2-3% yield; recommended for all children with unexplained developmental delay/intellectual disability
Thyroid Function Tests	Exclude hypothyroidism	Elevated TSH, low free T4	Usually detected on newborn screening; repeat if screening not done or uncertain
Lead Level	Detect lead toxicity	Blood lead ≥5 μg/dL is elevated; ≥45 μg/dL requires chelation	Especially important if pica, old housing, or environmental risk factors
Complete Audiologic Evaluation	Exclude hearing impairment	Any degree of hearing loss	Essential for all children with speech/language delay; even mild loss affects development
Vision Assessment	Exclude visual impairment	Refractive errors, strabismus, cortical visual impairment	Formal ophthalmologic evaluation if concerns; cortical visual impairment common with brain injury

Chromosomal Microarray: The New First-Line Test

Chromosomal microarray (CMA) has replaced standard karyotype as the first-line genetic test for developmental delay. CMA detects submicroscopic deletions and duplications that karyotype cannot see. Key points:

Diagnostic yield: 15-20% in global developmental delay (compared to ~3% for karyotype)
Limitations: Does not detect balanced translocations, low-level mosaicism, or single gene mutations
Variants of uncertain significance (VUS): May be found in 5-10% of cases; require careful interpretation
Parental testing: Often needed to interpret findings

Second-Tier Investigations: Based on Clinical Indication

Neuroimaging

Modality	When to Order	What to Look For	Practical Considerations
MRI Brain	Abnormal neurological examination, microcephaly, macrocephaly, regression, seizures, focal findings, cerebral palsy	Structural malformations, white matter abnormalities, myelination pattern, atrophy, lesions	Yield 30-50% when indicated; often requires sedation in young children; consider MR spectroscopy for metabolic disorders
CT Head	Acute presentations, suspicion of calcifications, when MRI not available	Intracranial calcifications (congenital infection, tuberous sclerosis), acute hemorrhage	Higher radiation; less sensitive than MRI for most pathology; no sedation needed
Cranial Ultrasound	Neonates with open fontanelle	Hemorrhage, ventriculomegaly, cysts, major malformations	No sedation, no radiation; limited resolution for cortical abnormalities

Electroencephalography (EEG)

Indication	What to Look For	Clinical Significance
Clinical seizures	Epileptiform discharges, seizure patterns	Confirms epilepsy diagnosis, guides treatment
Developmental regression	Epileptiform activity, hypsarrhythmia, continuous spike-wave in sleep	May indicate epileptic encephalopathy (treatable cause of regression)
Suspected infantile spasms	Hypsarrhythmia (chaotic, high-amplitude pattern)	Urgent diagnosis needed — treatment delay worsens outcomes
Staring episodes or behavioral arrest	Absence seizures, focal discharges	May explain attention/learning problems; treatable
Acquired aphasia	Centrotemporal spikes, electrical status epilepticus in sleep	Landau-Kleffner syndrome — may respond to treatment

Metabolic Investigations

When to Consider Metabolic Testing

Metabolic disorders account for 5-10% of global developmental delay. Yield is higher with specific clinical features. Consider metabolic workup when:

Developmental regression
Episodic decompensation (encephalopathy with illness)
Hepatosplenomegaly or organomegaly
Coarse facial features
Unusual odor (body, urine)
Failure to thrive
Consanguinity (increased risk of autosomal recessive conditions)
Family history of early death or similar condition

Test	What It Detects	Key Findings
Plasma Amino Acids	Aminoacidopathies	Elevated phenylalanine (PKU), elevated homocysteine, maple syrup urine disease pattern
Urine Organic Acids	Organic acidemias	Methylmalonic acid, propionic acid metabolites, glutaric acid
Plasma Acylcarnitine Profile	Fatty acid oxidation defects, organic acidemias	Characteristic acylcarnitine patterns
Lactate and Pyruvate	Mitochondrial disorders, pyruvate metabolism defects	Elevated lactate, abnormal lactate/pyruvate ratio (>20 suggests mitochondrial)
Ammonia	Urea cycle defects	Elevated ammonia; may be episodic
Urine Glycosaminoglycans	Mucopolysaccharidoses	Elevated total GAGs, abnormal pattern
Lysosomal Enzyme Panel	Lysosomal storage disorders	Deficient enzyme activity (specific to condition)
Very Long Chain Fatty Acids	Peroxisomal disorders (adrenoleukodystrophy)	Elevated VLCFA ratios
Urine Purines and Pyrimidines	Purine/pyrimidine metabolism disorders	Abnormal metabolite patterns (e.g., Lesch-Nyhan)
Transferrin Isoelectric Focusing	Congenital disorders of glycosylation	Abnormal transferrin pattern

Advanced Genetic Testing

Test	When to Consider	Yield and Limitations
Whole Exome Sequencing (WES)	Negative CMA and Fragile X; clinical features suggestive of genetic etiology; unexplained global developmental delay	25-40% additional diagnostic yield after negative first-tier testing; identifies single gene disorders; may find VUS
Whole Genome Sequencing (WGS)	Negative WES; suspicion of structural variants, intronic mutations, or regulatory region variants	Higher yield than WES in some studies; detects CNVs and sequence variants; more data to interpret
Gene Panels	Specific clinical phenotype (e.g., epilepsy panel, muscular dystrophy panel, autism panel)	Targeted approach; may be faster and cheaper than exome; misses genes not on panel
Methylation Studies	Suspected imprinting disorder (Angelman, Prader-Willi), unexplained developmental delay with specific features	Detects abnormal methylation patterns; diagnoses Angelman, Prader-Willi, some cases of Fragile X
Mitochondrial DNA Sequencing	Suspected mitochondrial disorder (multisystem disease, elevated lactate, characteristic MRI findings)	Detects mtDNA mutations; nuclear genes also cause mitochondrial disease (require WES)

Targeted Investigations by Clinical Presentation

Motor Delay with Hypotonia and Weakness

First-Line Tests

Creatine kinase (CK): Markedly elevated in Duchenne muscular dystrophy (10-100x normal), moderately elevated in other myopathies
SMN1 gene testing: For spinal muscular atrophy (most common genetic cause of infant death)
Dystrophin gene (DMD) testing: If CK elevated in male

Second-Line Tests

EMG/Nerve conduction studies: Distinguish myopathy from neuropathy
Muscle biopsy: If genetic testing negative; histology, immunohistochemistry
Neuromuscular gene panel or WES: For undiagnosed cases

Developmental Regression

Urgent Investigations

EEG: Rule out epileptic encephalopathy
MRI brain: Structural lesions, white matter disease
Metabolic screen: Amino acids, organic acids, lactate, ammonia
Lumbar puncture: If infection or autoimmune encephalitis suspected (glucose, protein, cell count, oligoclonal bands, neurotransmitters)

Additional Testing

Lysosomal enzyme panel: Storage disorders
MECP2 gene testing: Rett syndrome (girls with regression)
Autoimmune encephalitis panel: Anti-NMDA receptor and other antibodies
Genetic testing: WES if above negative

Autism Spectrum Disorder Evaluation

Investigation	Rationale	Yield
Audiologic evaluation	Exclude hearing loss contributing to communication deficits	Essential for all
Chromosomal microarray	High rate of copy number variants in autism	10-15% diagnostic yield
Fragile X testing	Most common inherited cause of intellectual disability with autism features	1-3% yield in autism
MECP2 testing	Consider in girls with autism features, especially with regression	Low but important if positive
PTEN testing	If macrocephaly (>97th percentile) with autism	Up to 10% if macrocephalic
EEG	Consider if history of regression, seizure-like episodes	Higher rate of epileptiform activity in autism
MRI brain	Consider if abnormal neurological exam, macrocephaly, seizures	Low yield in autism without other features
Whole exome sequencing	If CMA and other testing negative; multiple genes associated with autism	10-30% additional yield

Investigation Algorithm Summary

Stepwise Approach to Investigating Global Developmental Delay:

All children: Chromosomal microarray, Fragile X testing, thyroid function, lead level, hearing test, vision assessment
If abnormal neurological exam or specific features: MRI brain
If seizures or regression: EEG (urgent), metabolic workup, MRI brain
If hypotonia with weakness: CK, SMN1 gene testing, consider EMG/NCS
If features of metabolic disease: Comprehensive metabolic workup
If first-tier genetic testing negative: Consider whole exome sequencing
If all testing negative: Re-evaluate periodically; new tests become available; phenotype may evolve

Special Considerations for Investigation

Newborn Screening: Don’t Assume It’s Complete

Newborn screening programs vary by region and have evolved over time. Key points:

Verify screening was done — request results, not just “normal” report
Know what was screened: Core conditions vary; some states screen for 30+ conditions, others fewer
False negatives occur: Phenylketonuria, hypothyroidism, and others can be missed
Lysosomal storage disorders: Only recently added to some screening panels
Consider repeat testing if high clinical suspicion despite negative screen

The Role of the “Diagnostic Odyssey”

Many families of children with developmental delay experience a prolonged diagnostic journey. Modern genetic testing is changing this landscape:

Rapid whole genome sequencing: Now available for critically ill infants; results in days
Reanalysis of genetic data: As new gene-disease associations are discovered, prior testing can be reinterpreted
Matchmaker databases: Connect families with similar rare variants worldwide
Research participation: Undiagnosed programs may offer additional testing options

Interpreting Results and Next Steps

Result	Interpretation	Next Steps
Pathogenic variant identified	Diagnosis confirmed	Genetic counseling; connect with condition-specific resources; surveillance for associated features; family testing
Likely pathogenic variant	Probable diagnosis	Similar to pathogenic; consider additional testing if uncertainty; parental testing helpful
Variant of uncertain significance (VUS)	Uncertain clinical relevance	Do not use for diagnosis; parental testing may help; may be reclassified over time; continue clinical care
Negative genetic testing	No diagnosis from this test	Does not exclude genetic cause; consider additional testing; reassess as new tests available; focus on intervention
Metabolic abnormality identified	Potential treatable condition	Confirm with additional testing; urgent metabolic consultation; initiate treatment if indicated
Structural brain abnormality on MRI	May explain delay; guides further workup	Correlate with clinical features; consider genetic testing for malformations; prognostic counseling

7. Clinical Decision-Making

Practical algorithms and decision pathways for developmental delay

Step 1: Is This Urgent?

Clinical Scenario	Urgency Level	Immediate Action
Developmental regression (loss of skills)	EMERGENT	Same-day neurology referral; EEG, MRI, metabolic workup urgently; consider admission
New-onset seizures with developmental concerns	EMERGENT	EEG urgently (within days); infantile spasms require treatment within 1-2 weeks of diagnosis
Acute encephalopathy or change in consciousness	EMERGENT	Emergency department evaluation; consider metabolic crisis, infection, structural lesion
Signs of increased intracranial pressure	EMERGENT	Emergency neuroimaging; neurosurgical consultation
Rapidly progressive weakness	EMERGENT	Assess respiratory function; urgent neuromuscular evaluation; consider spinal muscular atrophy, Guillain-Barré
Severe hypotonia in infant with feeding/breathing difficulties	URGENT	Inpatient evaluation; SMN1 testing; assess for neuromuscular respiratory failure
Concern for non-accidental injury	URGENT	Child protection evaluation; neuroimaging; skeletal survey; ophthalmologic exam
Global developmental delay identified	URGENT	Refer to early intervention (do not wait for diagnosis); initiate first-tier investigations; developmental pediatrics/neurology referral within 2-4 weeks
Isolated speech delay with normal hearing	ROUTINE	Confirm hearing is normal; refer to speech therapy; developmental monitoring; consider autism screening
Mild motor delay, otherwise well	ROUTINE	Refer to physical/occupational therapy; developmental monitoring; consider evaluation if not improving

Critical Principle: Never “Wait and See” Without a Plan

When developmental delay is identified, immediate action is always warranted:

Refer to early intervention services — do not wait for a diagnosis; eligibility is based on delay, not etiology
Schedule follow-up — set a specific timeline for reassessment (typically 2-3 months)
Initiate investigations — begin first-tier testing while awaiting specialty appointments
Document specific concerns and milestones — quantify the delay for future comparison

Step 2: Classify the Developmental Concern

Isolated Delay (Single Domain)

Proceed to Algorithm A

Identify affected domain
Domain-specific workup
Lower yield for genetic testing
Better prognosis overall

Global Delay (≥2 Domains)

Proceed to Algorithm B

Comprehensive evaluation
First-tier genetic testing
Higher diagnostic yield
More intensive intervention

Regression (Loss of Skills)

Proceed to Algorithm C (Urgent)

Expedited evaluation
Rule out treatable causes
EEG, MRI, metabolics
Neurology consultation

Step 3: Follow the Appropriate Algorithm

Algorithm A: Isolated Developmental Delay

Domain Affected	First Steps	If Persists/Worsens
Isolated Motor Delay	Physical therapy evaluation; assess tone (hypotonia vs. hypertonia); if hypotonia with weakness → CK, SMN1 testing	MRI brain; neurology referral; consider neuromuscular evaluation; genetic testing
Isolated Speech/Language Delay	Audiologic evaluation (mandatory); speech therapy referral; autism screening (M-CHAT)	If hearing normal: developmental evaluation for autism; consider EEG if regression; Fragile X testing
Isolated Social/Communication Delay	Autism-specific evaluation (ADOS-2); hearing test; developmental assessment	Chromosomal microarray; Fragile X; consider MECP2 (girls); WES if syndromic features
Isolated Cognitive Delay	Formal cognitive testing; hearing and vision assessment; first-tier genetic testing	MRI brain; metabolic workup; WES if no diagnosis

Algorithm B: Global Developmental Delay

Systematic Approach to Global Developmental Delay:

Refer to early intervention immediately — do not wait for diagnostic workup
Complete first-tier investigations: Chromosomal microarray, Fragile X, thyroid function, lead level, hearing test, vision assessment
Based on clinical features, add:
- MRI brain (if abnormal neurological exam, microcephaly, macrocephaly, seizures, regression)
- EEG (if seizures, regression, staring spells)
- Metabolic workup (if regression, episodic symptoms, organomegaly, failure to thrive)
- CK and SMN1 (if hypotonia with weakness)
If first-tier testing negative: Consider whole exome sequencing
If all testing negative: Continue intervention; re-evaluate periodically; consider research enrollment

Algorithm C: Developmental Regression (Urgent Pathway)

Step	Action	Timeline
1. Confirm regression	Detailed history of lost skills; review developmental records, videos, photos	At initial visit
2. Urgent neurology referral	Expedited appointment; communicate urgency to scheduling	Within 1-2 weeks
3. EEG	Prolonged or overnight EEG if possible; rule out epileptic encephalopathy	Within 1-2 weeks
4. MRI brain with spectroscopy	Look for structural lesions, white matter disease, metabolic patterns	Within 2-4 weeks
5. Metabolic workup	Amino acids, organic acids, lactate, ammonia, lysosomal enzymes	Initiate immediately
6. Genetic testing	CMA, Fragile X; MECP2 (girls); consider gene panel or WES	Initiate immediately
7. Consider lumbar puncture	If infectious, inflammatory, or neurotransmitter disorder suspected	Based on clinical picture

“What Do I Do If…” Decision Reference

Clinical Situation	Immediate Action	Next Steps
Parent expresses concern about development but child “passes” screening	Take parental concern seriously; do not dismiss	Refer for formal developmental evaluation; parental concern is highly predictive; schedule close follow-up
Child has developmental delay but family resistant to evaluation	Explore concerns and barriers; provide education about early intervention benefits	Emphasize therapy helps regardless of diagnosis; offer to start with intervention before extensive testing
Chromosomal microarray returns “variant of uncertain significance”	Do not use VUS to explain developmental delay	Offer parental testing (may help classify); continue diagnostic workup; VUS may be reclassified over time
All first-tier testing is negative	Reassure family that diagnosis is not required for intervention	Consider whole exome sequencing; continue early intervention; re-evaluate in 6-12 months; consider undiagnosed disease programs
Child is not making expected progress despite therapy	Re-evaluate diagnosis and appropriateness of current interventions	Consider additional diagnoses (autism? hearing loss? regression?); adjust therapy intensity/type; specialist re-evaluation
Family asks about prognosis with unknown etiology	Acknowledge uncertainty honestly	Provide general information based on severity of delay; emphasize that early intervention improves outcomes regardless; avoid overly optimistic or pessimistic predictions
Older sibling has intellectual disability; parents concerned about new baby	Offer genetic counseling	Review prior testing; consider testing older sibling with current technology; discuss prenatal testing options for future pregnancies if etiology known
Child with developmental delay also has behavioral concerns	Address both simultaneously	Screen for autism; consider ADHD evaluation if age-appropriate; behavioral therapy; medication may be appropriate for some conditions
Premature infant is “delayed” — is this real delay?	Use corrected age for assessment (until age 2 for motor/cognitive, 18 months for head circumference)	If delayed even for corrected age, evaluate and intervene; premature infants at higher risk for true developmental delay
Genetic diagnosis is made — what now?	Connect family with condition-specific resources; genetic counseling for recurrence risk	Surveillance for associated features (cardiac, renal, etc.); adjust expectations and interventions based on natural history; family testing as appropriate

Referral Pathway Decision Guide

Referral	When to Refer	What They Provide
Early Intervention (ages 0-3)	Any confirmed or suspected developmental delay	Therapy services (PT, OT, speech); family support; service coordination
Special Education (ages 3+)	Developmental delay affecting educational progress	Individualized Education Program (IEP); specialized instruction; related services
Developmental-Behavioral Pediatrics	Global developmental delay; suspected autism; complex developmental concerns	Comprehensive developmental evaluation; diagnosis; care coordination
Pediatric Neurology	Abnormal neurological examination; regression; seizures; motor delay with abnormal tone; suspected neurodegenerative disease	Neurological evaluation; neuroimaging interpretation; EEG; management of epilepsy
Genetics	Dysmorphic features; multiple congenital anomalies; family history; positive genetic testing; consanguinity	Syndrome identification; genetic testing guidance; recurrence risk counseling
Metabolic/Biochemical Genetics	Suspected metabolic disorder; regression; episodic symptoms; abnormal metabolic screening	Metabolic workup; dietary management; enzyme replacement therapy when available
Neuromuscular Clinic	Hypotonia with weakness; elevated CK; suspected muscular dystrophy or myopathy	EMG/NCS; muscle biopsy coordination; management of neuromuscular conditions
Audiology	All children with speech/language delay; failed hearing screen; recurrent ear infections	Comprehensive hearing evaluation; hearing aid fitting; cochlear implant evaluation
Ophthalmology	Visual concerns; strabismus; suspected cortical visual impairment; syndromes with eye involvement	Vision assessment; refractive correction; eye muscle surgery; retinal evaluation

Troubleshooting: When Progress Is Not as Expected

Ask These Questions When the Child Is Not Improving

Is the diagnosis correct? — Re-evaluate; could there be an additional or different diagnosis?
Has regression occurred? — Loss of skills changes the differential dramatically
Is hearing truly normal? — Repeat audiologic evaluation; consider auditory processing disorder
Is the therapy appropriate and of adequate intensity? — Consider increasing frequency or changing approach
Are there barriers to therapy participation? — Transportation, caregiver availability, financial constraints
Are there comorbid conditions? — Undiagnosed autism, ADHD, anxiety, sleep disorders can impede progress
Are medications interfering? — Sedating medications may affect function
Is there uncontrolled epilepsy? — Subclinical seizures can impair development; consider repeat EEG
Are home environment factors contributing? — Psychosocial stressors, inadequate stimulation, neglect
Is it time for additional genetic testing? — New tests become available; WES if not already done

8. Clinical Pearls and Pitfalls

Practical wisdom — learn from successes and avoid common mistakes

Must-Know Clinical Pearls

Parental concern is predictive: Research consistently shows that when parents express concern about their child’s development, they are usually right. Take parental concern seriously even if the child appears to “pass” screening tests. The sensitivity of parental concern for developmental delay is 70-80%.

Early intervention works regardless of diagnosis: Do not delay referral to early intervention while pursuing a diagnostic workup. The benefits of early therapy are well-established, and eligibility is based on developmental delay, not specific etiology. Start therapy immediately.

Chromosomal microarray is the new first-line genetic test: CMA has replaced karyotype as the initial genetic investigation for developmental delay. It has a 15-20% diagnostic yield compared to approximately 3% for standard karyotype and detects submicroscopic deletions and duplications that karyotype cannot see.

Regression is always a red flag: Loss of previously acquired skills fundamentally changes the differential diagnosis. Regression suggests an active, potentially treatable process (epileptic encephalopathy, metabolic disorder, structural lesion) and requires urgent evaluation with EEG, MRI, and metabolic studies.

Hearing must be tested in all children with speech delay: Hearing impairment is a treatable cause of speech and language delay. Never assume hearing is normal. Even mild hearing loss can significantly impact language development. Formal audiologic evaluation is mandatory.

Use corrected age for premature infants: When assessing developmental milestones in premature infants, use corrected age (chronological age minus weeks of prematurity) until age 2 years for motor and cognitive milestones. Failing to correct for prematurity leads to inappropriate concern or missed actual delays.

Hypotonia with weakness suggests neuromuscular disease: Central hypotonia (brain-based) typically presents with hypotonia but preserved strength, while peripheral hypotonia (neuromuscular) presents with both hypotonia and weakness. This distinction guides investigation — weakness prompts CK testing and SMN1 gene analysis.

Absence of diagnosis does not mean absence of condition: Despite comprehensive evaluation, 30-50% of children with global developmental delay will not have an identifiable cause. This does not mean there is no underlying condition. Reassure families that intervention is appropriate regardless, and new diagnostic tools may yield answers in the future.

Critical Pitfalls to Avoid

“Let’s wait and see” without a clear plan: This is the most common and harmful mistake. Telling parents to “wait and see” delays early intervention during the critical window of brain plasticity. Always provide a specific timeline for reassessment and immediately refer to early intervention services.

Dismissing parental concern when screening appears normal: Standardized screening tools are not perfect. Parents know their child best. If parents are concerned but the child passes screening, refer for formal developmental evaluation anyway. Missing early signs of delay can significantly impact outcomes.

Assuming speech delay in a boy is “just late talking”: While constitutional language delay exists, isolated speech delay in boys can be the first sign of autism spectrum disorder, hearing impairment, or intellectual disability. All children with speech delay need hearing testing and autism screening at minimum.

Ordering karyotype instead of chromosomal microarray: Standard karyotype misses most pathogenic copy number variants. Chromosomal microarray is now the recommended first-line genetic test for developmental delay with 5-7 times higher diagnostic yield. Reserve karyotype for suspected aneuploidy or when balanced translocation is being specifically excluded.

Forgetting to test for Fragile X: Fragile X syndrome is the most common inherited cause of intellectual disability and is frequently associated with autism features. It should be tested in all children with unexplained developmental delay or intellectual disability, regardless of family history, as most cases are new mutations.

Attributing delay to prematurity without proper assessment: While premature infants are at higher risk for developmental delay, not all delay in a former preemie is due to prematurity. Use corrected age for assessment, but if the child is delayed even for corrected age, investigate further. Premature infants can also have genetic conditions.

Missing infantile spasms: Infantile spasms are subtle and easily missed. They appear as brief clusters of head drops, body flexion, or arm extension. Developmental regression or stagnation in the first year of life, especially around 4-8 months, should prompt urgent EEG. Early treatment significantly improves outcomes.

Stopping investigation after finding one abnormality: Children can have multiple contributing factors to their developmental delay. Finding one abnormality (e.g., prematurity, mild hearing loss) does not mean the evaluation is complete. Consider whether the identified factor fully explains the degree of delay observed.

Using a variant of uncertain significance to explain developmental delay: VUS findings on genetic testing should not be used to make a diagnosis or explain a child’s condition. Counsel families that VUS may be reclassified over time but currently cannot be used for definitive diagnosis or recurrence risk counseling.

Forgetting that normal MRI does not exclude pathology: Many causes of developmental delay — including genetic syndromes, autism spectrum disorder, and some metabolic disorders — present with normal brain MRI. A normal MRI is reassuring for certain conditions but does not exclude an underlying cause of delay.

Key Takeaways

Early identification matters: Developmental delay affects 5-10% of children. Early identification and intervention during the period of maximal brain plasticity significantly improves outcomes.
Intervene first, investigate simultaneously: Refer to early intervention services immediately when delay is identified. Do not wait for diagnostic evaluation to complete before starting therapy.
Systematic evaluation yields diagnoses: Comprehensive evaluation identifies an etiology in 50-70% of children with global developmental delay. Chromosomal microarray and Fragile X testing are first-tier genetic tests.
Regression is a red flag: Loss of previously acquired skills suggests an active pathological process and requires urgent evaluation. Consider epileptic encephalopathy, metabolic disorders, and neurodegenerative conditions.
Hearing testing is mandatory: All children with speech and language delay must have formal audiologic evaluation. Hearing impairment is common and treatable.
Distinguish central from peripheral hypotonia: Hypotonia with preserved strength suggests central (brain) pathology; hypotonia with weakness suggests neuromuscular disease. This distinction guides investigation.
Genetic testing is evolving: Whole exome sequencing provides 25-40% additional diagnostic yield when first-tier testing is negative. New genetic causes are being discovered continuously.
No diagnosis is not no condition: Many children will not receive a specific diagnosis despite comprehensive evaluation. This does not diminish the reality of their delay or the value of intervention.
Family support is essential: The diagnosis of developmental delay affects the entire family. Connect families with support services, parent groups, and appropriate resources throughout the diagnostic journey.
Re-evaluation is valuable: Children should be periodically re-evaluated. New symptoms may emerge, new tests become available, and genetic data can be reanalyzed as knowledge advances.

Quick Reference Algorithm

Systematic Approach to Developmental Delay:

Identify the delay: Use standardized developmental surveillance and screening at every well-child visit. Take parental concerns seriously.
Characterize the delay: Determine which domains are affected (isolated vs. global), severity, and pattern (static vs. regression).
Refer to early intervention immediately: Do not wait for diagnosis. Eligibility is based on delay, not etiology.
Initiate first-tier investigations: Chromosomal microarray, Fragile X, thyroid function, lead level, hearing test, vision assessment for all children with global developmental delay.
Add targeted investigations based on clinical features: MRI brain, EEG, metabolic workup, neuromuscular evaluation as indicated by examination and history.
If regression present: Expedite evaluation — urgent EEG, MRI, and metabolic studies. Consider treatable causes (epileptic encephalopathy, hydrocephalus, metabolic disorders).
If first-tier testing negative: Consider whole exome sequencing. Continue intervention regardless of diagnostic status.
Provide family support and counseling: Connect with genetic counseling, support groups, and condition-specific resources when diagnosis is made.
Monitor and re-evaluate: Schedule regular follow-up. Reassess progress, adjust interventions, and consider additional testing as new options become available.
Coordinate care: Developmental delay often requires multidisciplinary management including developmental pediatrics, neurology, genetics, therapy services, and educational support.